Medistim ASA (LON:0OCD)

Market Cap	205.76M
Revenue (ttm)	38.39M
Net Income (ttm)	7.20M
Shares Out	n/a
EPS (ttm)	0.39
PE Ratio	28.57
Forward PE	n/a
Dividend	0.33 (0.21%)
Ex-Dividend Date	Apr 25, 2024

Volume	4,270
Average Volume	193
Open	158.00
Previous Close	155.00
Day's Range	158.00 - 158.00
52-Week Range	158.00 - 300.00
Beta	0.76
RSI	50.69
Earnings Date	Feb 28, 2025

About Medistim ASA

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Europe, Asia, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplan...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 1984
• Employees: 151
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0OCD

Financial Performance

In 2023, Medistim ASA's revenue was 521.11 million, an increase of 7.17% compared to the previous year's 486.26 million. Earnings were 103.82 million, a decrease of -8.91%.

Financial numbers in NOK